K71.5
Toxic liver disease with chronic active hepatitis
Clinical Classification Guidelines
Inclusion Terms
- Toxic liver disease with lupoid hepatitis
Medical Intelligence & Overview
Toxic liver disease with chronic active hepatitis, classified under ICD-10 code K71.5, is a condition where the liver becomes inflamed due to exposure to harmful substances. This condition often involves ongoing liver inflammation (chronic active hepatitis) that results from toxic injury, which may be caused by various chemicals, drugs, or environmental toxins. The term 'lupoid hepatitis' refers to a specific type of autoimmune-like, chronic inflammation that can resemble lupus in its immune response. Recognizing and understanding this condition is crucial for effective management and prevention of severe liver damage.
Causes & Symptoms
Clinical Causes: Chronic exposure to hepatotoxic chemicals or toxins such as industrial chemicals, pesticides, or solvents Long-term use of certain medications, especially those with known liver side effects Ingestion of toxic substances including alcohol or certain herbal supplements Environmental toxins that accumulate in the body over time Autoimmune processes resembling lupoid hepatitis, where the immune system attacks liver cells Genetic predisposition increasing susceptibility to toxin-related liver damage
Key Symptoms: Fatigue and weakness Loss of appetite and weight loss Jaundice, which causes yellowing of the skin and eyes Abdominal pain or discomfort, especially in the upper right side Nausea and vomiting Dark urine and pale stool Swelling in the abdomen or legs due to fluid accumulation Elevated liver enzymes detected during blood tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. Healthcare providers typically perform blood work to check liver function, including levels of liver enzymes, bilirubin, and other markers of liver inflammation. Imaging studies such as ultrasound may be used to assess liver structure. In some cases, a liver biopsy is necessary to confirm the presence of inflammation, identify damage, and exclude other liver conditions. Additional tests to determine the cause, such as toxicology screenings or autoimmune panels, may also be performed.
Treatment Protocols: Treatment strategies focus on eliminating or reducing exposure to toxic substances and managing liver inflammation. Key components include: - Discontinuing or avoiding identified toxins and harmful substances - Supportive care to alleviate symptoms - Use of medications to suppress immune response if autoimmune features are present - Regular monitoring of liver function and disease progression - Nutritional support, including a balanced diet to support liver health - In severe cases, hospitalization or specialized interventions may be necessary The prognosis varies depending on the extent of liver damage and the effectiveness of exposure elimination. Early intervention can potentially halt or reverse the damage, while advanced cases require careful management to prevent liver failure.
Clinical Advice & FAQs
Billing Guidance
Is K71.5 a billable ICD-10 code?
Yes, K71.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K71.5?
Clinical documentation must specify the nature of Toxic liver disease with chronic active hepatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
